FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: JOINT MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE AND THE ANESTHETIC AND ANALGESIC DRUG PRODUCTS ADVISORY COMMITTEE; AMENDMENT OF NOTICE-EXTENDED-RELEASE/LONG-ACTING OPIOID ANALGESIC POSTMARKETING REQUIREMENT

WASHINGTON, April 21 -- Food and Drug Administration has issued a notice called: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee; Amendment of Notice-Extended-Release/Long-Acting Opioid Analgesic Postmarketing Requirement.

The notice was published in the Federal Register on April 21 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA) is announcing an amendment to the notice of joint meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee. This meeting was announced in the Federal Registero...